Cullen/Frost Bankers, Inc. Cooper Companies, Inc. Transaction History

Cullen/Frost Bankers, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$323.56 - $373.36 $970 - $1,120	-3 Reduced 25.0%	9 $3,000
Q4 2022 Feb 13, 2023	SELL	$248.67 - $334.17 $2,486 - $3,341	-10 Reduced 45.45%	12 $3,000
Q3 2022 Nov 07, 2022	BUY	$263.81 - $337.27 $791 - $1,011	3 Added 15.79%	22 $6,000
Q1 2022 May 09, 2022	BUY	$379.46 - $424.54 $7,209 - $8,066	19 New	19 $8,000
Q4 2020 Feb 08, 2021	SELL	$319.05 - $363.32 $957 - $1,089	-3 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$280.08 - $347.78 $840 - $1,043	3 New	3 $1,000
Q1 2020 May 01, 2020	SELL	$243.44 - $359.98 $13,876 - $20,518	-57 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$279.29 - $336.89 $15,919 - $19,202	57 New	57 $19,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.